Overview

Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH

Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study aimed to investigate the efficacy and safety of venetoclax combined with dexamethasone and etoposide as a salvage therapy for hemophagocytic lymphohistiocytosis.
Phase:
Phase 1
Details
Lead Sponsor:
Beijing Friendship Hospital
Treatments:
Dexamethasone
Etoposide
Venetoclax